Expanding Insurance Coverage of Cochlear Implants for Single-Sided Deafness
On January 10, 2022, the FDA approved an expansion of the Cochlear™ Nucleus® System indications to include Single Sided Deafness and Unilateral Hearing Loss (SSD/UHL) for individuals 5 years and […]